Xiuping Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiuping Wu has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Bing Li
Shanxi Medical University School and Hospital of Stomatology
30 shared publications Yifan Zhao
School and Hospital of Stomatology, Shanxi Medical University, Taiyuan, 030001, People’s Republic of China
16 shared publicationsJingyu Yan
Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, Shanxi, China. 2Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Taiyuan, 030001, Shanxi, China
15 shared publicationsLingxiang Sun
School and Hospital of Stomatology, Shanxi Medical University, Taiyuan, 030001, People’s Republic of China
15 shared publicationsYingyu Liu
Shanxi Medical University School and Hospital of Stomatology and Shanxi Provincial Engineering Research Center for Oral Biomaterials, Taiyuan, 030001, Shanxi, China
13 shared publicationsChenying Cui
Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, Shanxi, China. 2Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Taiyuan, 030001, Shanxi, China
9 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-32
Regulation of Mitochondrial Homeostasis: Applications of Nanobiomaterials in Age-Related Bone Diseases
Age-related bone diseases are a heterogeneous group of metabolic disorders characterized by progressive degenerative changes. Although nanobiomaterials have emerged as a promising means of regulation at the cellular level, their therapeutic efficacy remains very limited due to the lack of treatment strategies that directly target mitochondrial pathology. In recent years, nanobiomaterial therapies centered on mitochondria have attracted widespread attention. This review aims to critically evaluate the latest advances in this emerging field and categorize them into four main strategies: enhancing mitochondrial autophagy, optimizing the mitochondrial microenvironment, repairing mitochondrial structure, and implementing mitochondrial transfer therapy. Based on existing research, we have preliminarily established a multi-level intervention framework ranging from the clearance of dysfunctional mitochondria to the regulation of the microenvironment, and from the repair of structural components to the transplantation of healthy mitochondria, which has demonstrated encouraging proof-of-concept results in vitro and in animal models. However, this field remains in the preclinical exploration phase: the vast majority of studies are based on rodent models, the efficiency of mitochondrial-targeted delivery is generally low, and long-term biosafety and the feasibility of large-scale production have not yet been systematically evaluated. This review discusses the latest advances in mitochondrial-based nanobiomaterial therapies for age-related bone diseases. Furthermore, this review explores potential drugs and targets for the development of more effective nanobiomaterials, focusing on the key challenges facing the transition from the laboratory to clinical applications in this field, and is expected to provide novel insights into the future development of mitochondria-based nanobiomaterial therapies.
- 1 July 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-32
Open AccessRegulation of Mitochondrial Homeostasis: Applications of Nanobiomaterials in Age-Related Bone Diseases
Age-related bone diseases are a heterogeneous group of metabolic disorders characterized by progressive degenerative changes. Although nanobiomaterials have emerged as a promising means of regulation at the cellular level, their therapeutic efficacy remains very limited due to the lack of treatment strategies that directly target mitochondrial pathology. In recent years, nanobiomaterial therapies centered on mitochondria have attracted widespread attention. This review aims to critically evaluate the latest advances in this emerging field and categorize them into four main strategies: enhancing mitochondrial autophagy, optimizing the mitochondrial microenvironment, repairing mitochondrial structure, and implementing mitochondrial transfer therapy. Based on existing research, we have preliminarily established a multi-level intervention framework ranging from the clearance of dysfunctional mitochondria to the regulation of the microenvironment, and from the repair of structural components to the transplantation of healthy mitochondria, which has demonstrated encouraging proof-of-concept results in vitro and in animal models. However, this field remains in the preclinical exploration phase: the vast majority of studies are based on rodent models, the efficiency of mitochondrial-targeted delivery is generally low, and long-term biosafety and the feasibility of large-scale production have not yet been systematically evaluated. This review discusses the latest advances in mitochondrial-based nanobiomaterial therapies for age-related bone diseases. Furthermore, this review explores potential drugs and targets for the development of more effective nanobiomaterials, focusing on the key challenges facing the transition from the laboratory to clinical applications in this field, and is expected to provide novel insights into the future development of mitochondria-based nanobiomaterial therapies.
- Open Access
- 30 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30, 0396
Sonodynamic CoMg-Quercetin Nanozyme for Antibacterial Therapy and Multifunctional Bone Regeneration in Infectious Bone Defects
Infectious bone defects remain a serious clinical challenge because infection-associated inflammation markedly hinders bone regeneration. To address this complicated pathological condition, a porphyrin-doped cobalt-magnesium bimetallic quercetin-based sonosensitive nanozyme (CoMg-Que) was engineered to integrate antibacterial therapy, redox modulation, and tissue regenerative functions within a single platform. Upon ultrasound (US) irradiation, CoMg-Que was activated and efficiently generated reactive oxygen species (ROS) for sonodynamic antibacterial treatment. Following termination of US stimulation, its inherent superoxide dismutase- and catalase-like activities further removed excessive ROS, thereby relieving inflammatory responses and re-establishing redox homeostasis. In vitro experiments demonstrated that CoMg-Que effectively eliminated methicillin-resistant Staphylococcus aureus (MRSA) and exhibited favorable immunomodulatory, pro-angiogenic, and osteogenic properties. In an MRSA-infected rat calvarial defect model, CoMg-Que achieved an antibacterial efficiency of 95.24% and markedly enhanced bone regeneration, with the bone volume fraction reaching 26.76%. These findings indicate that CoMg-Que may serve as a promising multifunctional platform for infectious bone defect treatment through coordinated antibacterial, immunoregulatory, and regenerative activities.
- 30 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30, 0396
Open AccessSonodynamic CoMg-Quercetin Nanozyme for Antibacterial Therapy and Multifunctional Bone Regeneration in Infectious Bone Defects
Infectious bone defects remain a serious clinical challenge because infection-associated inflammation markedly hinders bone regeneration. To address this complicated pathological condition, a porphyrin-doped cobalt-magnesium bimetallic quercetin-based sonosensitive nanozyme (CoMg-Que) was engineered to integrate antibacterial therapy, redox modulation, and tissue regenerative functions within a single platform. Upon ultrasound (US) irradiation, CoMg-Que was activated and efficiently generated reactive oxygen species (ROS) for sonodynamic antibacterial treatment. Following termination of US stimulation, its inherent superoxide dismutase- and catalase-like activities further removed excessive ROS, thereby relieving inflammatory responses and re-establishing redox homeostasis. In vitro experiments demonstrated that CoMg-Que effectively eliminated methicillin-resistant Staphylococcus aureus (MRSA) and exhibited favorable immunomodulatory, pro-angiogenic, and osteogenic properties. In an MRSA-infected rat calvarial defect model, CoMg-Que achieved an antibacterial efficiency of 95.24% and markedly enhanced bone regeneration, with the bone volume fraction reaching 26.76%. These findings indicate that CoMg-Que may serve as a promising multifunctional platform for infectious bone defect treatment through coordinated antibacterial, immunoregulatory, and regenerative activities.
- Open Access
- 23 May 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Mitochondria-targeted nanozyme hydrogel remodels the microenvironment to enhance bone regeneration in diabetes-associated periodontitis
Diabetes-associated periodontitis is a multifactorial disease driven by metabolic disorders and chronic inflammation, featuring mitochondrial dysfunction,
- 23 May 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessMitochondria-targeted nanozyme hydrogel remodels the microenvironment to enhance bone regeneration in diabetes-associated periodontitis
Diabetes-associated periodontitis is a multifactorial disease driven by metabolic disorders and chronic inflammation, featuring mitochondrial dysfunction,
- Open Access
- 15 May 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103240
Self-oxidatively crosslinked sprayable hydrogel for microenvironment remodeling and accelerated healing of recurrent aphthous ulcers
- 15 May 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103240
Open AccessSelf-oxidatively crosslinked sprayable hydrogel for microenvironment remodeling and accelerated healing of recurrent aphthous ulcers
- 30 March 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 263, 115651
Corrigendum to “Temperature-responsive hydrogel delivery of antimicrobial peptide engineered watermelon-derived extracellular vesicles enables sequential infection control and wound healing” [Colloids Surf. B Biointerfaces 261 (2026) 115438]
- 30 March 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 263, 115651
Corrigendum to “Temperature-responsive hydrogel delivery of antimicrobial peptide engineered watermelon-derived extracellular vesicles enables sequential infection control and wound healing” [Colloids Surf. B Biointerfaces 261 (2026) 115438]
- Open Access
- 4 July 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 102057
The next generation of dental treatments: Leveraging smart-responsive nanomaterials for unique oral environments
- 4 July 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 102057
Open AccessThe next generation of dental treatments: Leveraging smart-responsive nanomaterials for unique oral environments
- Open Access
- 7 June 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-21
Zinc-doped curcumin carbon dots promote infected wound healing with photodynamic via the VEGF signaling pathway
Management of bacterial infected wounds remains challenging due to the open, susceptibility to infection and delayed healing characteristics of damaged wounds, and there is an urgent need for non-antibiotic-based wound healing strategies. Here, we describe zinc-doped curcumin carbon dots (CCDs) as a novel nanoscale photosensitizer, which was applied in photodynamic therapy (PDT) to promote infected wound healing by modulating various cellular functions. The PDT generation of reactive oxygen species (ROS) effectively inactivates the source of infection without drug resistance, effectively inhibiting the propagation of bacteria and the spread of inflammation in the wound. In addition, CCDs have the ability to promote cell proliferation and extension, accelerate blood vessel formation and collagen deposition, and significantly improve wound healing efficiency by modulating the VEGF signaling pathway. These features create a favorable environment for skin regeneration and synergistically accelerate infected wound healing. We believe it has great potential to address antibiotic misuse and effectively manage infected wounds.
- 7 June 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-21
Open AccessZinc-doped curcumin carbon dots promote infected wound healing with photodynamic via the VEGF signaling pathway
Management of bacterial infected wounds remains challenging due to the open, susceptibility to infection and delayed healing characteristics of damaged wounds, and there is an urgent need for non-antibiotic-based wound healing strategies. Here, we describe zinc-doped curcumin carbon dots (CCDs) as a novel nanoscale photosensitizer, which was applied in photodynamic therapy (PDT) to promote infected wound healing by modulating various cellular functions. The PDT generation of reactive oxygen species (ROS) effectively inactivates the source of infection without drug resistance, effectively inhibiting the propagation of bacteria and the spread of inflammation in the wound. In addition, CCDs have the ability to promote cell proliferation and extension, accelerate blood vessel formation and collagen deposition, and significantly improve wound healing efficiency by modulating the VEGF signaling pathway. These features create a favorable environment for skin regeneration and synergistically accelerate infected wound healing. We believe it has great potential to address antibiotic misuse and effectively manage infected wounds.
- Open Access
- 17 April 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101780
Dynamic multistage nanozyme hydrogel reprograms diabetic wound microenvironment: synergistic oxidative stress alleviation and mitochondrial restoration
- 17 April 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101780
Open AccessDynamic multistage nanozyme hydrogel reprograms diabetic wound microenvironment: synergistic oxidative stress alleviation and mitochondrial restoration
- Open Access
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 29, 0210
Nanozymes Empower Periodontitis Treatment: New Strategies and Clinical Application Prospects
Periodontitis is a chronic inflammatory disease mediated by the immune system. Its pathogenesis involves the interaction of multiple factors, among which the accumulation of dental plaque is considered the initial key factor in the onset of the disease. As the pathogenic bacteria in plaque proliferate and metabolites are released, the host’s immune system produces a strong response, leading to an inflammatory response and structural destruction of local tissues. Traditional treatment relies on mechanical scraping and antibiotics but suffers from tissue damage, difficulty in removing deep-seated bacteria, development of drug resistance, and insufficient modulation of complex pathomechanisms. Nanozymes, as a novel therapeutic tool with high efficiency, stability, and multifunctionality, can remove pathogenic bacteria, modulate inflammation, and promote tissue repair, as well as have better environmental stability and biocompatibility, which provides a new way for precise treatment of periodontal disease and tissue regeneration. In this paper, the pathophysiology of periodontitis was first elucidated, and the design strategy of nanozymes and their application classification for the treatment of periodontitis were also discussed. Then, the recent advances in treating periodontitis with nanozymes are summarized in terms of antibacterial, anti-inflammatory, and tissue regeneration. Finally, the problems and prospects for the development of nanozymes for the treatment of periodontitis are discussed in terms of current challenges in the treatment of periodontitis and the stimulation of innovative research on nanozymes drugs, with a view to the clinical translation of novel enzyme mimicry strategies and efficient nanozymes for periodontitis drugs.
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 29, 0210
Open AccessNanozymes Empower Periodontitis Treatment: New Strategies and Clinical Application Prospects
Periodontitis is a chronic inflammatory disease mediated by the immune system. Its pathogenesis involves the interaction of multiple factors, among which the accumulation of dental plaque is considered the initial key factor in the onset of the disease. As the pathogenic bacteria in plaque proliferate and metabolites are released, the host’s immune system produces a strong response, leading to an inflammatory response and structural destruction of local tissues. Traditional treatment relies on mechanical scraping and antibiotics but suffers from tissue damage, difficulty in removing deep-seated bacteria, development of drug resistance, and insufficient modulation of complex pathomechanisms. Nanozymes, as a novel therapeutic tool with high efficiency, stability, and multifunctionality, can remove pathogenic bacteria, modulate inflammation, and promote tissue repair, as well as have better environmental stability and biocompatibility, which provides a new way for precise treatment of periodontal disease and tissue regeneration. In this paper, the pathophysiology of periodontitis was first elucidated, and the design strategy of nanozymes and their application classification for the treatment of periodontitis were also discussed. Then, the recent advances in treating periodontitis with nanozymes are summarized in terms of antibacterial, anti-inflammatory, and tissue regeneration. Finally, the problems and prospects for the development of nanozymes for the treatment of periodontitis are discussed in terms of current challenges in the treatment of periodontitis and the stimulation of innovative research on nanozymes drugs, with a view to the clinical translation of novel enzyme mimicry strategies and efficient nanozymes for periodontitis drugs.